Navigation Links
Summit Yields One-of-a-Kind Opportunity To Reduce Prescription Drug Overdoses
Date:11/16/2012

NEWARK, Del., Nov. 16, 2012 /PRNewswire-USNewswire/ --Today, a not-for-profit organization presenting at the Delaware Prescription Drug Abuse Summit appealed to the event's host, Attorney General Beau Biden, for assistance in preventing medication overdoses.  The Center for Lawful Access and Abuse Deterrence (CLAAD) asked Biden to work closely with his father, Vice President Joe Biden, to ensure that federal regulators properly implement Obama-Biden Administration drug policies. 

During CLAAD's presentation at the summit, Director Michael Barnes warned that pain medications without added safety features could flood back into communities in the coming weeks if the Food and Drug Administration (FDA) fails to follow the Obama-Biden strategy.

In recent years, the makers of the opioid pain relievers OxyContin and Opana removed their traditional products from the market in favor of new versions designed to impede certain forms of intentional abuse.  Preliminary, peer-reviewed evidence indicates that dealers and abusers have less interest in the new drugs with abuse-deterrent features.[1]  The new medications cost no more to consumers than their prior formulations. 

Several drug companies have asked the FDA for approval to bring the old, more readily abused formulations of the drugs back to the market as early as January 2013. 

"The Administration's prescription drug abuse prevention plan provides express support for abuse-deterrent medications," Barnes said.

Earlier this month, CLAAD and nine other public health and safety organizations sent a letter to the FDA urging it to implement Obama-Biden policy, foster the transition to abuse-deterrent medications, and prevent the marketing of generic versions of the drugs that do not have similar safety features.

"At today's summit, I asked General Biden to work closely with his father to make certain that the FDA does the right thing," Barnes said. 

Vice President Biden is considered one of the most accomplished national leaders in drug policy, having served as chairman of both the U.S. Senate Judiciary Committee and Drug Caucus.

"I have confidence that the Bidens will ensure that the FDA supports the shift to abuse-deterrent medications," Barnes concluded.  "We reached a turning point in our nation's prescription drug abuse epidemic at today's summit." 

[1] Cicero TJ, Ellis MS, Surratt HL. Effect of abuse-deterrent formulation of OxyContin. New England Journal of Medicine. 2012;367(2):187-189.


'/>"/>
SOURCE CLAAD
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. GHX Reveals Roadmap to Stronger Healthcare Community at GHX Healthcare Supply Chain Summit
2. Dehaier Medical to Present at the CFA 2012 Cross-Continental Summit on Investment in Shanghai
3. Next Generation Pharmaceutical Manufacturing Summit Pushes the Envelope of Thought-Leadership at its September Summit in London
4. Daniel Sontupe, SVP, Director of Market Access, at The CementBloc, to Present on Uncovering the Value in a Patient Support Program at CBI Summit
5. GDS Internationals Fourth Next Generation Pharmaceutical Drug Development Summit Attracts an Unprecedented Delegation of Thought Leaders
6. Cleveland Clinics 2012 Medical Innovation Summit Highlights Orthopaedic Technologies
7. Brand new Solid Form Co-Crystals and Amorphous Focus Morning at the Pharmaceutical Co-Crystals and Amorphous Material 2012 Summits
8. Online Career Service Holds Third Virtual Job Summit
9. FDAnews announces Third Annual Pharmaceutical Labeling Summit
10. VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmology Innovation Summit Meetings
11. FDAnews announces Fifth Annual Risk Management & Drug Safety Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... develops, markets and sells medical devices and wearable sleep ... a strategic cooperation agreement with Hongyuan Supply Chain Management ... on June 20, 2016, to develop Dehaier,s new Internet ... agreement, Dehaier will leverage Hongyuan Supply Chain,s sales platform ...
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
(Date:6/24/2016)... MD (PRWEB) , ... June 24, 2016 , ... ... protocols for human induced pluripotent stem (iPS) cells and other difficult to transfect ... G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is a ...
Breaking Medicine News(10 mins):